In a newly published article by the Wall Street Journal, a team of Columbia and Cornell researchers led by Dr. Jeremy Mao [a member of StemSave’s Scientific Advisory Council] has developed a potential method to treat patients with torn menisci. The method involves 3D-printing a biodegradable scaffold of the meniscus, infusing it with growth factors, and implanting it into the knee. Once in the patient’s body, the growth factors should attract autologous [the patient’s own] stem cells to generate a new, natural meniscus.
For the four million patients suffering from meniscus tears every year, surgery to fully remove the meniscus is currently their only option. However, a meniscectomy leaves the cartilage in the patient’s joints to rub against itself, leading to early onset arthritis. By engaging the patient’s own stem cells, Dr. Mao hopes to regenerate the meniscus instead of removing it, resulting in healthier long term outcomes for patients.
Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™